These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
520 related items for PubMed ID: 25955444
1. Risk factors for post-ERCP pancreatitis and hyperamylasemia: A retrospective single-center study. He QB, Xu T, Wang J, Li YH, Wang L, Zou XP. J Dig Dis; 2015 Aug; 16(8):471-8. PubMed ID: 25955444 [Abstract] [Full Text] [Related]
2. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail. Sugimoto M, Takagi T, Suzuki R, Konno N, Asama H, Sato Y, Irie H, Watanabe K, Nakamura J, Kikuchi H, Waragai Y, Takasumi M, Hikichi T, Ohira H. World J Gastroenterol; 2018 Jun 14; 24(22):2392-2399. PubMed ID: 29904246 [Abstract] [Full Text] [Related]
10. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography. Kawaguchi Y, Ogawa M, Omata F, Ito H, Shimosegawa T, Mine T. World J Gastroenterol; 2012 Apr 14; 18(14):1635-41. PubMed ID: 22529693 [Abstract] [Full Text] [Related]
13. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis. Wang G, Xiao G, Xu L, Qiu P, Li T, Wang X, Wen P, Wen J, Xiao X. Pancreatology; 2018 Jun 14; 18(4):370-378. PubMed ID: 29550097 [Abstract] [Full Text] [Related]
14. Effects of Somatostatin and Indomethacin Mono or Combination Therapy on High-risk Hyperamylasemia and Post-pancreatitis Endoscopic Retrograde Cholangiopancreatography Patients: A Randomized Study. Wu Z, Xiao G, Wang G, Xiong L, Qiu P, Tan S. Surg Laparosc Endosc Percutan Tech; 2023 Oct 01; 33(5):474-479. PubMed ID: 37523580 [Abstract] [Full Text] [Related]
15. Needle-knife sphincterotomy: factors predicting its use and the relationship with post-ERCP pancreatitis (with video). Bailey AA, Bourke MJ, Kaffes AJ, Byth K, Lee EY, Williams SJ. Gastrointest Endosc; 2010 Feb 01; 71(2):266-71. PubMed ID: 20003969 [Abstract] [Full Text] [Related]
16. Risk factors for complications of ERCP in primary sclerosing cholangitis. Ismail S, Kylänpää L, Mustonen H, Halttunen J, Lindström O, Jokelainen K, Udd M, Färkkilä M. Endoscopy; 2012 Dec 01; 44(12):1133-8. PubMed ID: 23108808 [Abstract] [Full Text] [Related]
18. Selective biliary cannulation techniques for endoscopic retrograde cholangiopancreatography procedures and prevention of post- endoscopic retrograde cholangiopancreatography pancreatitis. Mukai S, Itoi T. Expert Rev Gastroenterol Hepatol; 2016 Jun 01; 10(6):709-22. PubMed ID: 26782710 [Abstract] [Full Text] [Related]
19. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis. Shin SH, So H, Cho S, Kim N, Baik GH, Lee SK, Park DH. J Gastroenterol Hepatol; 2020 Jul 01; 35(7):1201-1207. PubMed ID: 31830336 [Abstract] [Full Text] [Related]
20. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis. Takenaka M, Fujita T, Sugiyama D, Masuda A, Shiomi H, Sugimoto M, Sanuki T, Hayakumo T, Azuma T, Kutsumi H. J Hepatobiliary Pancreat Sci; 2014 Apr 01; 21(4):275-80. PubMed ID: 24039185 [Abstract] [Full Text] [Related] Page: [Next] [New Search]